The seriousness of microbial resistance combined with the lack of new antimicrobials has
increased interest in the development of antimicrobial peptides (AMPs) as novel …

Methicillin-resistant Staphylococcus aureus (MRSA) infections present a serious challenge
because of the emergence of resistance to numerous conventional antibiotics. Due to their …

The rapid increase of Methicillin-resistant Staphylococcus aureus (MRSA) infections and the
cross-resistance of MRSA to other antibiotics create an urgent demand for new therapeutic …

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) have become one
of the biggest threats to public health. To develop new antibacterial agents against MRSA, a …

The emergence of bacteria resistant to conventional antibiotics is of great concern in modern
medicine because it renders ineffectiveness of the current empirical antibiotic therapies …

The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious
threat to public health. Of particular concern are methicillin-resistant Staphylococcus aureus …

Natural antimicrobial peptides (AMPs) are promising candidates for developing a generation
of new antimicrobials to meet the challenge of antibiotic-resistant pathogens such as …

Since the bacterial resistance to antibiotics is increasing rapidly, numerous studies have
contributed to the design and synthesis of potent synthetic mimics of antimicrobial peptides …

Broad-spectrum antimicrobial peptides (AMPs) kill bacteria indiscriminately, increasing the
possibility of an ecological imbalance in the microbiota. To solve this problem, new types of …

Diversity of sequence and structure in naturally occurring antimicrobial peptides (AMPs)
limits their intensive structure–activity relationship (SAR) study. In contrast, peptidomimetics …